Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 28, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Key transaction details include:
- Shares Purchased: 612,724 ordinary shares
- Price Range: Lowest price of 373.00 pence; Highest price of 376.10 pence
- Volume Weighted Average Price: 374.5134 pence
- Post-Transaction Share Capital: 9,124,273,534 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of the purchased shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website in accordance with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 1, 2024 Buyback Programme.
- Confirm the remaining authorized share buyback capacity.
- Review the full trade breakdown at the provided RNS link for intraday pricing details.
- Check the company's website for updated share capital figures for disclosure threshold calculations.